Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - Loss AllowanceNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Long-Term Deferred Tax: 2017

Historic Long-Term Deferred Tax for RedHill Biopharma (RDHL) over the last 1 years, with Dec 2017 value amounting to $76.0 million.

  • RedHill Biopharma's Long-Term Deferred Tax was N/A to $76.0 million in Q4 2017 from the same period last year, while for Dec 2017 it was $76.0 million, marking a year-over-year change of. This contributed to the annual value of $76.0 million for FY2017, which is N/A change from last year.
  • Latest data reveals that RedHill Biopharma reported Long-Term Deferred Tax of $76.0 million as of FY2017.
  • RedHill Biopharma's 5-year Long-Term Deferred Tax high stood at $76.0 million for FY2017, and its period low was $76.0 million during FY2017.
  • Moreover, its 1-year median value for Long-Term Deferred Tax was $76.0 million (2017), whereas its average is $76.0 million.